0.2644
price down icon9.82%   -0.0288
after-market アフターアワーズ: .26 -0.0044 -1.66%
loading
前日終値:
$0.2932
開ける:
$0.29
24時間の取引高:
1.65M
Relative Volume:
1.01
時価総額:
$12.18M
収益:
-
当期純損益:
$-37.75M
株価収益率:
-0.0814
EPS:
-3.25
ネットキャッシュフロー:
$-30.91M
1週間 パフォーマンス:
-21.03%
1か月 パフォーマンス:
-7.23%
6か月 パフォーマンス:
-87.98%
1年 パフォーマンス:
-92.89%
1日の値動き範囲:
Value
$0.2314
$0.2933
1週間の範囲:
Value
$0.2314
$0.3395
52週間の値動き範囲:
Value
$0.224
$3.84

Cellectar Biosciences Inc Stock (CLRB) Company Profile

Name
名前
Cellectar Biosciences Inc
Name
セクター
Healthcare (1162)
Name
電話
(608) 441-8120
Name
住所
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Name
職員
11
Name
Twitter
@CellectarBio
Name
次回の収益日
2025-03-05
Name
最新のSEC提出書
Name
CLRB's Discussions on Twitter

CLRB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CLRB
Cellectar Biosciences Inc
0.2644 12.18M 0 -37.75M -30.91M -3.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.62 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.45 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
555.11 33.86B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
235.74 30.51B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
238.51 25.69B 3.81B -644.79M -669.77M -6.24

Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-05 再開されました Ladenburg Thalmann Buy
2020-07-01 開始されました Oppenheimer Outperform
2020-01-21 再開されました ROTH Capital Buy
2019-09-13 開始されました ROTH Capital Buy
2016-12-21 開始されました Ladenburg Thalmann Buy

Cellectar Biosciences Inc (CLRB) 最新ニュース

pulisher
Apr 03, 2025

Cellectar Biosciences (NASDAQ:CLRB) Coverage Initiated at StockNews.com - Defense World

Apr 03, 2025
pulisher
Mar 31, 2025

Financial Contrast: Cellectar Biosciences (NASDAQ:CLRB) versus Cyclacel Pharmaceuticals (NASDAQ:CYCC) - Defense World

Mar 31, 2025
pulisher
Mar 26, 2025

Cellectar Biosciences (NASDAQ:CLRB) Now Covered by StockNews.com - Defense World

Mar 26, 2025
pulisher
Mar 19, 2025

Cellectar Biosciences (CLRB) to Release Earnings on Wednesday - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Mar 18, 2025
pulisher
Mar 18, 2025

StockNews.com Begins Coverage on Cellectar Biosciences (NASDAQ:CLRB) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Cellectar Biosciences Enhances CEO and COO Severance Benefits - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

What is Roth Capital’s Estimate for CLRB FY2029 Earnings? - Defense World

Mar 17, 2025
pulisher
Mar 14, 2025

Earnings call transcript: Cellectar Biosciences Q4 2024 sees restructuring amid losses - Investing.com Australia

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences, Inc. (NASDAQ:CLRB) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlights: Strategic Restructuring and ... - Yahoo Finance

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Inc (CLRB) Q4 2024 Earnings Call Highlight - GuruFocus.com

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Faces Financial and Legal Turmoil Amidst Restated Earnings - TipRanks

Mar 14, 2025
pulisher
Mar 14, 2025

Cellectar Biosciences Advances Cancer Drug Pipeline - TipRanks

Mar 14, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences Earnings Call: Mixed Outlook Amid Successes and Challenges - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences Reports Financial Results for Year Ended 2024 and Provides a Corporate Update - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar's Breakthrough: 83.6% Response Rate Puts FDA Fast Track Within Reach - StockTitan

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences Provides Update on FDA Regulatory Path for Iopofosine I 131 in Waldenström Macroglobulinemia and Advances Phase 1 Trials for New Radioconjugates - Nasdaq

Mar 13, 2025
pulisher
Mar 13, 2025

Cellectar Biosciences COO acquires $8,400 in stock By Investing.com - Investing.com Canada

Mar 13, 2025
pulisher
Mar 12, 2025

Cellectar Biosciences COO acquires $8,400 in stock - Investing.com India

Mar 12, 2025
pulisher
Mar 11, 2025

Cellectar Biosciences to Present at the 37th Annual Roth Conference - Quantisnow

Mar 11, 2025
pulisher
Mar 11, 2025

Cellectar Biosciences Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 11, 2025
pulisher
Mar 11, 2025

Cellectar Biosciences, Inc. to Present at 37th Annual Roth Conference - Nasdaq

Mar 11, 2025
pulisher
Mar 11, 2025

Cancer Treatment Breakthrough? Cellectar Biosciences Reveals Latest Progress at Major Investor Conference - StockTitan

Mar 11, 2025
pulisher
Mar 10, 2025

Before You Invest, Make Sure You Check This Cellectar Biosciences Inc (NASDAQ: CLRB) Analysis - stocksregister.com

Mar 10, 2025
pulisher
Mar 10, 2025

Cellectar Biosciences (NASDAQ:CLRB) Now Covered by Analysts at StockNews.com - Defense World

Mar 10, 2025
pulisher
Mar 08, 2025

Cellectar Biosciences (CLRB) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 08, 2025
pulisher
Mar 05, 2025

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Thursday, March 13, 2025 - GlobeNewswire

Mar 05, 2025
pulisher
Mar 05, 2025

Cellectar Biosciences, Inc. to Report 2024 Financial Results and Corporate Update on March 13, 2025 - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

When Will Cellectar Biosciences Reveal Its 2024 Financial Performance? - StockTitan

Mar 05, 2025
pulisher
Mar 02, 2025

StockNews.com Initiates Coverage on Cellectar Biosciences (NASDAQ:CLRB) - Defense World

Mar 02, 2025
pulisher
Feb 10, 2025

CLRB’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 10, 2025
pulisher
Feb 10, 2025

Prepare Yourself for Liftoff: Cellectar Biosciences Inc (CLRB) - SETE News

Feb 10, 2025
pulisher
Feb 07, 2025

SEC Form 424B3 filed by Cellectar Biosciences Inc. - Quantisnow

Feb 07, 2025
pulisher
Feb 06, 2025

A look into Cellectar Biosciences Inc (CLRB)’s deeper side - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Feb 06, 2025
pulisher
Feb 05, 2025

Cellectar Biosciences, Inc. to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025 - Nasdaq

Feb 05, 2025
pulisher
Feb 05, 2025

Cellectar Biosciences Showcases Cancer Treatment Pipeline at Major Healthcare Conference - StockTitan

Feb 05, 2025
pulisher
Feb 05, 2025

Examining Cellectar Biosciences Inc (CLRB) stock is warranted - US Post News

Feb 05, 2025
pulisher
Feb 04, 2025

Cellectar faces Nasdaq delisting over share price rule - MSN

Feb 04, 2025

Cellectar Biosciences Inc (CLRB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
大文字化:     |  ボリューム (24 時間):